KeyBanc Starts DaVita (DVA) at Buy

December 17, 2013 4:26 PM EST
Get Alerts DVA Hot Sheet
Price: $63.85 -0.13%

Rating Summary:
    7 Buy, 11 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 35 | Down: 31 | New: 11
Trade DVA Now!
Join SI Premium – FREE
KeyBanc initiated coverage on DaVita (NYSE: DVA) with a Buy rating and price target of $73.00.

Analyst Jason Gurda said, "With valuations at or above historical highs, we have focused our investment ratings on the longer-term growth potential and positioning, as well as potential sources of upside over the next year or two. We believe DVA is well managed and positioned for accelerating earnings growth over the next few years due to the expansion of its Healthcare Partners’ integrated care business and improving margins at recent acquisitions/partnerships. We believe the current reimbursement challenges are already in the stock and see the current valuation as reasonable based on cash flows."

For an analyst ratings summary and ratings history on DaVita click here. For more ratings news on DaVita click here.

Shares of DaVita closed at $60.02 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS View, New Coverage

Related Entities

KeyBanc, Earnings

Add Your Comment